飛利浦專注於成功執行其三年計劃，以在具有挑戰性的宏觀環境中推動運營改善並創造可持續影響的價值。 飛利浦對2025年的預期如下： • 可比銷售額增長1%-3%，其中包括中國市場中個位數的中高段下降。 • 調整後的EBITA利潤率將提高30-80個基點，達到11.8%-12.3%。 • 在支付與美國醫療監控和人身傷害和解相關的11億美元現金支出之前，自由現金流將在14億至16億歐元的下限。扣除這筆現金支出後，自由現金流將爲4億至6億歐元。

以上內容來自Benzinga Earnings專欄，原文如下：

Philips remains focused on successfully executing its three-year plan to drive operational improvements and create value with sustainable impact, within a challenging macro environment. 

For 2025, Philips expects: 

• 1%-3% comparable sales growth, including a mid- to high-single-digit decline in China

 • Adjusted EBITA margin increasing 30-80 bps to 11.8%-12.3% 

• Free cash flow before payment of the USD 1.1 billion cash-out relating to the US medical monitoring and personal injury settlements will be at the lower end of the range of EUR 1.4 billion to EUR 1.6 billion. Net of this cash-out, free cash flow will be EUR 0.4 billion to EUR 0.6 billion.